Zhongyan Du

533 total citations · 1 hit paper
18 papers, 318 citations indexed

About

Zhongyan Du is a scholar working on Epidemiology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Zhongyan Du has authored 18 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Zhongyan Du's work include Liver Disease Diagnosis and Treatment (6 papers), Alcohol Consumption and Health Effects (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Zhongyan Du is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Alcohol Consumption and Health Effects (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Zhongyan Du collaborates with scholars based in China, United States and Australia. Zhongyan Du's co-authors include Canhua Huang, Hui Ming, Edouard C. Nice, Siyuan Qin, Jingsi Dong, Bowen Li, Xiaobing Dou, Songtao Li, Qinchao Ding and Zhenyuan Song and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Zhongyan Du

17 papers receiving 314 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Redox regulation: mechanisms, biology and therapeutic targets in diseases

2025 71 citations Bowen Li, Hui Ming et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhongyan Du China	10	114	68	37	36	36	18	318
Fengqin Wang China	11	136 1.2×	52 0.8×	14 0.4×	41 1.1×	28 0.8×	31	406
Chitra Palanivel India	8	166 1.5×	53 0.8×	30 0.8×	29 0.8×	15 0.4×	16	445
Sun-Mee Lee South Korea	10	147 1.3×	41 0.6×	18 0.5×	34 0.9×	22 0.6×	13	360
Xiaowen Bao China	10	166 1.5×	33 0.5×	25 0.7×	35 1.0×	12 0.3×	12	364
Nor Azizan Abdullah Malaysia	8	114 1.0×	50 0.7×	17 0.5×	33 0.9×	73 2.0×	10	352
Xiaohua Cui China	10	148 1.3×	33 0.5×	16 0.4×	46 1.3×	26 0.7×	27	397
Faizan Ahmed United States	9	92 0.8×	29 0.4×	27 0.7×	50 1.4×	14 0.4×	20	298
Xi Wu China	9	141 1.2×	37 0.5×	10 0.3×	39 1.1×	38 1.1×	18	352
Juan Nie China	11	176 1.5×	40 0.6×	12 0.3×	33 0.9×	23 0.6×	17	406

Countries citing papers authored by Zhongyan Du

Since Specialization

Citations

This map shows the geographic impact of Zhongyan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongyan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongyan Du more than expected).

Fields of papers citing papers by Zhongyan Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongyan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongyan Du. The network helps show where Zhongyan Du may publish in the future.

Co-authorship network of co-authors of Zhongyan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongyan Du. A scholar is included among the top collaborators of Zhongyan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongyan Du. Zhongyan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Li, Bowen, Hui Ming, Siyuan Qin, et al.. (2025). Redox regulation: mechanisms, biology and therapeutic targets in diseases. Signal Transduction and Targeted Therapy. 10(1). 72–72. 71 indexed citations breakdown →

Cheng, Wenke, et al.. (2024). Sex Differences in “Life’s Essential 8” Cardiovascular Health and Type 2 Diabetes Mellitus Risk Across Menopause Stages. The Journal of Clinical Endocrinology & Metabolism. 110(3). 787–800. 1 indexed citations

Chen, Yang, Hui Ming, Bowen Li, et al.. (2024). A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer. Journal of Controlled Release. 376. 659–677. 27 indexed citations

Ruan, Xixian, Xing Wu, Xuejie Chen, et al.. (2024). Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease. Diabetes Obesity and Metabolism. 27(2). 866–875.

Guo, Rui, Wenbo Hu, Xuezhu Wang, et al.. (2024). Xie Zhuo Tiao Zhi formula ameliorates chronic alcohol-induced liver injury in mice. Frontiers in Pharmacology. 15. 1363131–1363131. 2 indexed citations

Sun, Yuhao, Xuejie Chen, Tian Fu, et al.. (2024). Greater adherence to the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet is associated with lower risk of inflammatory bowel disease: a prospective cohort study. Food & Function. 15(14). 7631–7640. 6 indexed citations

Cheng, Wenke, Zhongyan Du, & Bo Lü. (2024). Chronic low-grade inflammation associated with higher risk and earlier onset of cardiometabolic multimorbidity in middle-aged and older adults: a population-based cohort study. Scientific Reports. 14(1). 22635–22635. 14 indexed citations

Chen, Xuejie, Yuhao Sun, Tian Fu, et al.. (2024). Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up. International Journal of Surgery. 110(7). 4275–4285. 5 indexed citations

Tian, Hailong, et al.. (2024). Nanoengineering Calcium Peroxide‐Based Site‐Specific Delivery Platform to Efficiently Activate the cGAS‐STING Pathway for Cancer Immunotherapy by Amplified Endoplasmic Reticulum Stress. Advanced Functional Materials. 34(18). 12 indexed citations

10.

Qiu, Jiannan, Lin Chen, Ling Zhang, et al.. (2023). Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy. Phytomedicine. 121. 155111–155111. 41 indexed citations

11.

Lu, Shuaijun, Hailong Tian, Bowen Li, et al.. (2023). An Ellagic Acid Coordinated Copper‐Based Nanoplatform for Efficiently Overcoming Cancer Chemoresistance by Cuproptosis and Synergistic Inhibition of Cancer Cell Stemness. Small. 20(17). e2309215–e2309215. 30 indexed citations

12.

Wang, Linyan, et al.. (2022). Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis. Chinese Herbal Medicines. 14(2). 283–293. 27 indexed citations

13.

Du, Zhongyan, et al.. (2022). Atractylenolide I Ameliorates Acetaminophen-Induced Acute Liver Injury via the TLR4/MAPKs/NF-κB Signaling Pathways. Frontiers in Pharmacology. 13. 797499–797499. 39 indexed citations

14.

Ding, Qinchao, Li Zhou, Ai Fu, et al.. (2021). Activation of AMP-Activated Protein Kinase-Sirtuin 1 Pathway Contributes to Salvianolic Acid A-Induced Browning of White Adipose Tissue in High-Fat Diet Fed Male Mice. Frontiers in Pharmacology. 12. 614406–614406. 12 indexed citations

15.

Dou, Xiaobing, Wenwen Yang, Qinchao Ding, et al.. (2021). Comprehensive Analysis of the Expression Profiles of Hepatic lncRNAs in the Mouse Model of Alcoholic Liver Disease. Frontiers in Pharmacology. 12. 709287–709287. 5 indexed citations

16.

Ding, Lei, et al.. (2017). Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARα activation and subsequent 4-HNE degradation. PLoS ONE. 12(10). e0186357–e0186357. 22 indexed citations

17.

Du, Zhongyan, Xiaobing Dou, Jia Gao, et al.. (2013). Preparation, Drug Releasing Property and Pharmacodynamics of Soy Isoflavone-Loaded Chitosan Microspheres. PLoS ONE. 8(11). e79698–e79698. 3 indexed citations

18.

Du, Zhongyan, et al.. (2013). [Synergistic action of 4-hydroxynonenal and tumor necrosis factor involving the NF-kB/IkBa signaling pathway in alcohol-induced liver injury].. PubMed. 21(10). 747–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact